Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

19.43
+0.53002.80%
Post-market: 19.430.00000.00%16:10 EST
Volume:297.43K
Turnover:5.74M
Market Cap:1.02B
PE:- -
High:19.80
Open:18.90
Low:18.83
Close:18.90
52wk High:29.16
52wk Low:16.80
Shares:52.52M
Float Shares:17.65M
Volume Ratio:1.98
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-62.4570
ROE:-26.50%
ROA:-14.80%
PB:-7.71
PE(LYR):-0.31

Loading ...

Jan 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 05, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 19, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 30, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 17, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

Major Issues Report

Form 8-K - Current report
Oct 11, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Oct 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 20, 2024

Major Issues Report

Form 8-K - Current report
Sep 12, 2024

Major Issues Report

Form 8-K - Current report